Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01693120 · ClinicalTrials.gov registry record · NA
Evaluation of the Phased Radio Frequency Ablation System
A NA study, sponsored by Medtronic Cardiac Ablation Solutions.
- Terminated
- Registry status
- NA
- Development phase
- 199
- Enrollment target
NCT01693120: Clinical Trial NA study, sponsored by Medtronic Cardiac Ablation Solutions.
NCT01693120 is a NA study that was terminated before completion, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 199 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01693120, a NA study, was terminated before completion, sponsored by Medtronic Cardiac Ablation Solutions.
- TERMINATED
- Registry status
- NA
- Development phase
- 199 participants
- Enrollment target
Study Summary
VICTORY AF is an IDE, prospective global, multi-center, single arm, controlled, unblinded, investigational clinical study. The purpose of this clinical study is to evaluate the risk of procedure and/or device related strokes in subjects with persistent or long-standing persistent atrial fibrillation (AF) undergoing ablation with the Phased RF System.
Primary Outcome
A stroke with with a symptom onset date within 30 days of an ablation procedure where at least one Phased RF ablation catheter was deployed into the left atrium considered related to the procedure and/or the investigational device by the independent clinical events committee
Interventions
- DEVICE Medtronic Phased RF Ablation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2013-11 |
| Est. Completion | 2017-02-07 |
| Phase | NA |
Why NCT01693120 stopped before completion
NCT01693120 is an interventional study that assigns participants to a tested intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Medtronic Phased RF Ablation System is the first listed.
NCT01693120 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01693120 about?
NCT01693120 is a clinical study titled "Evaluation of the Phased Radio Frequency Ablation System". VICTORY AF is an IDE, prospective global, multi-center, single arm, controlled, unblinded, investigational clinical study. The purpose of this clinical study is to evaluate the risk of procedure and/or device related strokes in subjects with persistent or long-standing persistent atrial fibrillation...
What is the current status of trial NCT01693120?
This trial is currently terminated. It is a NA study. The enrollment target is 199 participants. The study started on 2013-11. Estimated completion is 2017-02-07.
What interventions are being tested in trial NCT01693120?
The interventions under investigation include: Medtronic Phased RF Ablation System (DEVICE).
Who is sponsoring clinical trial NCT01693120?
This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01693120's enrollment target sits among peer trials
199 567th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04312126 · 199 participants
The Beneficial Effects of Naps on Motor Learning
- NCT04951622 · 199 participants · Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- NCT06474533 · 199 participants
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia